ÂÜÀòÂÒÂ×

Dr. Hegg brings over 20 years of Research and Development (R&D) and leadership experience to Avalo Therapeutics as Senior Vice President, Program Management and Corporate Infrastructure. Prior to joining the company, Dr. Hegg served as Vice President, Development and Project Management at Aclaris Therapeutics, where she led dermatology and immune-inflammation early- and mid-stage development programs. Prior to Aclaris, Dr. Hegg held the role of VP, Head of Project and Planning & Management as well as Medicine Development Leader at GlaxoSmithKline (GSK) where she oversaw multi-disciplinary teams through early- and late-stage drug development, market launch, and postapproval processes. Following her postdoctoral fellowship at the University of Massachusetts Medical Center, Dr. Hegg began her industry career at GSK in R&D Discovery where she held significant project management and leadership roles in cardiovascular, metabolic, pulmonary, immuno-inflammatory, dermatology, and urogenital programs/products. Dr. Hegg received her BS from Muhlenberg College and her Ph.D. from Clark University.